GDF1 and neoplasm: In addition, although prometastatic GDF1 is strongly associated with a poor prognosis in C57BL/6 mice, anti-PD1 therapy dramatically reversed malignant progression and significantly prolonged the overall survival of C57BL/6 mice bearing GDF1-overexpressing tumours (Fig. 6c).